Victory Capital Management
XTNT icon

Victory Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Victory Capital Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,154
Closed -$8K – 2756
2022
Q1 		$8K Sell
12,154
-347
-3% -$227 ﹤0.01% 2688
2021
Q4 		$7K Sell
12,501
-375
-3% -$353 ﹤0.01% 2749
2021
Q3 		$14K Sell
12,876
-650
-5% -$845 ﹤0.01% 2745
2021
Q2 		$22K Buy
13,526
+1,013
+8% +$1.8K ﹤0.01% 2705
2021
Q1 		$30K Buy
12,513
+562
+5% +$1.2K ﹤0.01% 2702
2020
Q4 		$14K Buy
+11,951
New +$15.4K ﹤0.01% 2512
2020
Q2 		– Sell
-4,378
Closed -$2K – 3313
2020
Q1 		$2K Buy
+4,378
New +$5.29K ﹤0.01% 3684
2019
Q4 		– Sell
-2,246
Closed -$6K – 3303
2019
Q3 		$6K Buy
+2,246
New +$6.24K ﹤0.01% 3418

Other funds holding XTNT

ACM
Altium Capital Management New York $42M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return